{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Private Equity", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Endo International PLC", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "TPG Capital", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Generic Brands and Products", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Stocks and Bonds", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Dublin (Ireland)", "name": "glocations", "rank": "8", "is_major": "N"}, {"value": "Pennsylvania", "name": "glocations", "rank": "9", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/19/business/dealbook/endo-international-to-pay-8-05-billion-for-par-pharmaceutical.html", "document_type": "article", "byline": {"person": [{"lastname": "BRAY", "firstname": "Chad", "role": "reported", "organization": "", "rank": 1}], "original": "By CHAD BRAY"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "415", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "The deal would create a specialty pharmaceutical company that would be one of the five largest generic drug makers based on sales in the United States.", "pub_date": "2015-05-19T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Drug Maker Merger Would Create Powerhouse in Generics ", "main": "Endo International to Pay $8.05 Billion for Par Pharmaceutical"}, "print_page": null, "snippet": "The deal would create a specialty pharmaceutical company that would be one of the five largest generic drug makers based on sales in the United States.", "_id": "5559d6b638f0d873642285ba", "slideshow_credits": null, "abstract": null}